Molecular sampling of prostate cancer: a dilemma for predicting disease progression

• Main Authors: Mucci Lorelei A (Author), Fall Katja (Author), Adami Hans-Olov (Author), Perner Sven (Author), Hoshida Yujin (Author), Setlur Sunita R (Author), Pawitan Yudi (Author), Calza Stefano (Author), Demichelis Francesca (Author), Sboner Andrea (Author), Kantoff Philip W (Author), Stampfer Meir (Author), Andersson Swen-Olof (Author), Varenhorst Eberhard (Author), Johansson Jan-Erik (Author), Gerstein Mark B (Author), Golub Todd R (Author), Rubin Mark A (Author), Andrén Ove (Author)
• Format: Book
• Published: BMC, 2010-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence,...